This page shows you the latest news items in this category. This is page number 4.
Total 12382 results found since Jan 2013.
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
Condition: Myopia Interventions: Drug: 0.01% atropine; Other: 0.9% sodium chloride Sponsor: He Eye Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Conditions: Myopia; Juvenile Myopia; Myopia Progression Interventions: Device: Single vision, impact-resistant spectacle lenses; Test Arm; Device: Single vision, impact-resistant spectacle lenses; Control Arm Sponsor: SightGlass Vision, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
Condition: Myopia Interventions: Device: CP1; Drug: 0.01% atropine Sponsors: Kubota Vision Inc.; China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials